- Apr 2, 2016
- 1,037
- 364
GW0742 is a PPAR delta agonist that improves both energy and endurance, which means you can work out harder and longer while also getting leaner.
What is GW0742?
GW0742 was developed by Glaxo Smith Kline who is best known for making Cardarine.
GW0742 and Cardarine are very similar, having just a single atom’s difference in their molecular makeup.
Although it’s grouped with SARMs, GW0742 is a PPAR agonist. Its key function is to break down the fatty acids in your stored energy reserves to provide your body with extra energy.
The method of action of GW7042 is almost identical to that of Cardarine, however, it is more powerful in its fat-burning action.
PPAR Agonist
GW0742 is a PPAR (peroxisome proliferator-activated receptor) agonist. PPAR agonists are a group of nuclear receptor proteins that regulate gene expression.
There are three main classes of PPAR agonists:
PPAR alpha agonists
PPAR gamma agonist
PPAR delta agonists
The main function of PPAR alpha agonists is to lower cholesterol and triglyceride levels.
PPAR gamma agonists mainly work to control blood glucose levels. This drug is mainly developed for use with diabetics.
PPAR delta agonists are designed to switch over the body’s preferred fuel energy system from carbohydrate-derived glucose to lipids from stored body fat.
PPAR Delta Agonist
GW0742 is a PPAR delta agonist. Delta is also known as NR1C2 and it turns on the genes that are responsible for fat metabolism. These proteins are found all over the body but are most prolific in the muscles, heart, and liver.
In addition to increasing lipid uptake for energy, the delta agonist also affects the way that your body responds to exercise. In improving stored fat utilization, this protein also helps to protect you from fatty liver disease.
The PPAR delta agonist can control your energy use during endurance-type exercise. It will prioritize fat burning during the workout and preserve your glucose supplies.
The effect of this is that you have a longer-lasting supply of energy and, therefore, more endurance. Studies have shown that supplementation with a PPAR delta agonist (GW0742) improves running endurance significantly.
GW0742
GW0742 is a PPAR delta agonist designed to affect the peroxisome proliferator-activated receptor protein to improve its ability to burn stored body fat. This, in turn, improves training energy and endurance so that you can work out harder and longer while also getting leaner.
What is GW0742?
GW0742 was developed by Glaxo Smith Kline who is best known for making Cardarine.
GW0742 and Cardarine are very similar, having just a single atom’s difference in their molecular makeup.
Although it’s grouped with SARMs, GW0742 is a PPAR agonist. Its key function is to break down the fatty acids in your stored energy reserves to provide your body with extra energy.
The method of action of GW7042 is almost identical to that of Cardarine, however, it is more powerful in its fat-burning action.
PPAR Agonist
GW0742 is a PPAR (peroxisome proliferator-activated receptor) agonist. PPAR agonists are a group of nuclear receptor proteins that regulate gene expression.
There are three main classes of PPAR agonists:
PPAR alpha agonists
PPAR gamma agonist
PPAR delta agonists
The main function of PPAR alpha agonists is to lower cholesterol and triglyceride levels.
PPAR gamma agonists mainly work to control blood glucose levels. This drug is mainly developed for use with diabetics.
PPAR delta agonists are designed to switch over the body’s preferred fuel energy system from carbohydrate-derived glucose to lipids from stored body fat.
PPAR Delta Agonist
GW0742 is a PPAR delta agonist. Delta is also known as NR1C2 and it turns on the genes that are responsible for fat metabolism. These proteins are found all over the body but are most prolific in the muscles, heart, and liver.
In addition to increasing lipid uptake for energy, the delta agonist also affects the way that your body responds to exercise. In improving stored fat utilization, this protein also helps to protect you from fatty liver disease.
The PPAR delta agonist can control your energy use during endurance-type exercise. It will prioritize fat burning during the workout and preserve your glucose supplies.
The effect of this is that you have a longer-lasting supply of energy and, therefore, more endurance. Studies have shown that supplementation with a PPAR delta agonist (GW0742) improves running endurance significantly.
GW0742
GW0742 is a PPAR delta agonist designed to affect the peroxisome proliferator-activated receptor protein to improve its ability to burn stored body fat. This, in turn, improves training energy and endurance so that you can work out harder and longer while also getting leaner.
